CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Semret, M.
Right arrow Articles by Behr, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Semret, M.
Right arrow Articles by Behr, M. A.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, September 2006, p. 991-996, Vol. 13, No. 9
1071-412X/06/$08.00+0     doi:10.1128/CVI.00217-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Genetic Analysis of Mycobacterium avium Complex Strains Used for Producing Purified Protein Derivatives

Makeda Semret,1 Douwe Bakker,2 Nonie Smart,3 Ingrid Olsen,4 Kaare Haslov,5 and Marcel A. Behr1*

McGill University Health Centre, Montreal, Quebec, Canada,1 CIDC-Lelystad, Lelystad, The Netherlands,2 Canadian Food Inspection Agency, Nepean, Ontario, Canada,3 National Veterinary Institute, Oslo, Norway,4 Statens Serum Institut, Copenhagen, Denmark5

Received 6 June 2006/ Returned for modification 3 July 2006/ Accepted 7 July 2006

For over a century, purified protein derivatives (PPD) have been used to detect mycobacterial infections in humans and livestock. Among these, reagents to detect infections by Mycobacterium avium complex organisms have been produced, but the utility of these reagents has not been clearly established due in part to limited biologic and immunologic standardization. Because there is little information about the strains used to produce these reagents (avian PPD, intracellulare PPD, scrofulaceum PPD, and Johnin), we have performed genetic characterizations of strains used to produce these products. Sequence analysis of 16S rRNA and the hsp65 gene provided results concordant with species designations provided for M. avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum organisms. For M. avium strains, comparative genomic hybridization was performed on a whole-genome DNA microarray, revealing one novel 7.9-kilobase genomic deletion in certain Johnin-producing strains, in addition to genomic variability inherent to the particular M. avium subspecies. Our findings indicate that considerable genomic differences exist between organisms used for reagents and the infecting organism being studied. These results serve as a baseline for potency studies of different preparations and should aid in comparative studies of newly discovered antigens for the diagnosis of infection and disease by M. avium complex organisms.


* Corresponding author. Mailing address: A5-156, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. Phone: (514) 934-1934, ext. 42815. Fax: (514) 934-8423. E-mail: marcel.behr{at}mcgill.ca.


Clinical and Vaccine Immunology, September 2006, p. 991-996, Vol. 13, No. 9
1071-412X/06/$08.00+0     doi:10.1128/CVI.00217-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.